Introduction to Symprove Acquisition
One of the UK’s leading makers of probiotic supplements is set to be taken over by an American competitor as demand for gut health and wellbeing products booms. Symprove, which was launched by its founder on a Surrey farm in 2010, is being bought by Metagenics, a New Jersey-based nutritional supplements supplier.
Background of Symprove
The company conceived its water-based formula as a treatment for livestock before concluding that it would also have a positive impact on human gut health. It has since become one of the UK’s leading probiotic brands and is considered the most recommended brand by doctors. Symprove’s products can provide effective treatment for patients with irritable bowel syndrome (IBS) as well as the stomach problems of other diseases.
Growth and Expansion
The company capitalizes on consumers’ growing interest in gut health and its impact on their overall physical and mental well-being. Under its current leadership, the company has grown into Europe’s largest subscription company of its kind since 2020, with managing director driving rapid annual revenue increases.
Acquisition Details
The deal is expected to be announced and will represent a windfall for Symprove’s private equity backer and the company’s other shareholders. The price paid by Metagenics was unclear. Sources said Symprove had received takeover interest from a wide range of strategic and financial investors, but its owners had prioritized finding a new owner who could expand its international reach while maintaining its scientific focus.
About Metagenics
Metagenics is backed by a US-based private investment firm that advised on the acquisition. The deal marks the first investment exit for Symprove’s private equity backer, which was co-founded by industry leaders. Neither the private equity backer nor Symprove could be reached for comment on the sale. The acquisition is set to boost Symprove’s global presence and continue its mission to provide effective probiotic supplements for gut health and wellbeing.
